Akorn (AKRX) News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period May 15, 2023 | thestreet.comAkorn Reaches New 52-Week High (AKRX)October 20, 2022 | businesswire.comCarlin Consumer Health Names Scott Chapman Chief Executive Officer - Business WireOctober 10, 2022 | prnewswire.comVeterinary Eye Care Market Size to record USD 788.78 Million Growth at a CAGR of 4.65% by 2026, Evolving Opportunities with Bausch Health Co Inc. And Akorn Operating Co. - Technavio - PR NewswireOctober 9, 2022 | fortune.comA small fund wagered that Elon Musk would be forced to buy Twitter—and made a killing by betting against the crowd - FortuneSeptember 29, 2022 | finance.yahoo.comDiuretic Drugs Market to Record a CAGR of 5.44%, Increasing Incidence of Hypertension Among People to Drive Growth - Technavio - Yahoo FinanceSeptember 15, 2022 | moodys.comMoody's downgrades Akorn to Caa2; revises outlook to stable from positive - Moody'sSeptember 2, 2022 | nasdaq.comPrestige Consumer (PBH) Brands & E-commerce Strength Bode Well - NasdaqAugust 29, 2022 | businesswire.comThe Worldwide Inhalation & Nasal Sprays Generic Drugs Industry is Expected to Reach $11.2 Billion by 2027 - ResearchAndMarkets.com - Business WireAugust 27, 2022 | fortune.comShort-sellers, lawyers, and academics predict the odds Elon Musk will be forced to close on a $44 billion deal he hates - FortuneAugust 26, 2022 | businesswire.comThe Worldwide Glaucoma Treatment Industry is Expected to Reach $9.1 Billion by 2027 - ResearchAndMarkets.com - Business WireAugust 26, 2022 | globenewswire.comConjunctivitis Market to Grow at a Healthy CAGR of 5.8% from 2022 to 2032 Owing to Growing Disease Prevalence Globally | Future Market Insights, Inc. - GlobeNewswireAugust 23, 2022 | law360.comWhistleblower Claims Rattle Twitter's Bid To Force Musk Deal - Law360August 17, 2022 | bloomberg.comAkorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg - BloombergAugust 16, 2022 | prnewswire.comAkorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg - PR NewswireAugust 11, 2022 | globenewswire.comPterygium Drug Market Trends, Shares, Key Players, Regional Overview and Market Is Growing At CAGR Of 6.2% By 2029 - GlobeNewswireAugust 5, 2022 | law360.comDelaware Powerhouse: Paul Weiss - Law360August 4, 2022 | streetinsider.comPrestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023 - StreetInsider.comAugust 1, 2022 | finance.yahoo.comThe Global Animal Sedative Market is expected to grow by $ 190.96 mn during 2022-2026, accelerating at a CAGR of 5.85% during the forecast period - Yahoo FinanceJuly 26, 2022 | globenewswire.comUM6P Ventures Invests in Akorn Technology to Reduce Global Food Waste - GlobeNewswireJuly 20, 2022 | prnewswire.comBleeding Disorders Treatment Market to Receive Irresistible Growth of USD 11.65 Billion by 2029 with Size, Share Global Industry Trends, Top Players and Revenue Analysis - PR NewswireJuly 14, 2022 | law360.comIllinois Cases To Watch In 2nd Half Of 2022 - Law360July 11, 2022 | fortune.comThe fight between Musk and Twitter will come down to 3 words—and they rarely work - FortuneJuly 9, 2022 | reuters.comAnalysis: Twitter has legal edge in deal dispute with Musk - Reuters.comJune 14, 2022 | nasdaq.comPrestige Consumer (PBH) Brand-Building Efforts Solid, Costs High - NasdaqJune 10, 2022 | finance.yahoo.comThe Global Anaplastic Thyroid Cancer Drugs Market is expected to grow by $ 230.53 mn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period - Yahoo FinanceJune 7, 2022 | businesswire.comGlobal Eye Drop (Prescription v/s Over-the-Counter) Markets, Analysis, Competition, Forecast and Opportunities, 2017-2021 & 2022-2027 - ResearchAndMarkets.com - Business WireJune 7, 2022 | forbes.comElon Musk's Twitter Deal Has Become A Multibillion-Dollar Game Of Chicken - ForbesMay 30, 2022 | businesswire.comGlobal Glaucoma Treatment Market Report (2022 to 2032) - Players Include Aerie Pharmaceuticals, Cipla, Abbvie and Akorn Operating Company - ResearchAndMarkets.com - Business WireMay 17, 2022 | businesswire.comGlobal Clindamycin Phosphate Injection Market to 2027 - Featuring Akorn, Baxter International and Pfizer Among Others - ResearchAndMarkets.com - Business WireMay 17, 2022 | finance.yahoo.comGlobal Clindamycin Phosphate Injection Market to 2027 - Featuring Akorn, Baxter International and Pfizer Among Others - ResearchAndMarkets.com - Yahoo FinanceMay 14, 2022 | washingtonpost.comElon Musk can't use Twitter bots to get out out of acquisition agreement - The Washington PostMay 6, 2022 | finance.yahoo.comPrestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat - Yahoo FinanceMay 5, 2022 | globenewswire.comPrestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022 - GlobeNewswireMay 4, 2022 | nasdaq.comWhat's in Store for Prestige Consumer (PBH) in Q4 Earnings? - NasdaqMay 4, 2022 | finance.yahoo.comGlobal eye drop market was valued at USD13530 million in 2021 and is anticipated to grow with a CAGR of 6.46% during the forecast period to achieve a market value of USD19758 million by 2027 - Yahoo FinanceApril 23, 2022 | businesswire.comGlobal Antispasmodics Drugs Market Research Report to 2027 - Increasing Patient Awareness Level and Improvement in Treatment Presents Opportunities - ResearchAndMarkets.com - Business WireApril 20, 2022 | finance.yahoo.comGlobal Veterinary Eye Care Market - Growth, Trends, and Forecasts (2022 - 2027) - ResearchAndMarkets.com - Yahoo FinanceMarch 18, 2022 | finance.yahoo.comBronchitis Treatment Market Size to Grow by USD 1.12 bn | Technavio - Yahoo FinanceMarch 16, 2022 | finance.yahoo.comDry Eye Medication Global Market Report 2022 - Yahoo FinanceMarch 14, 2022 | nasdaq.comPrestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce - NasdaqMarch 10, 2022 | nasdaq.comWhy Is Model N (MODN) Down 6% Since Last Earnings Report? - NasdaqMarch 9, 2022 | prnewswire.comAkorn Announces Completion of the Sale of its Branded Ophthalmic Products to Théa Pharma - PR NewswireFebruary 9, 2022 | finance.yahoo.comModel N Announces First Quarter Fiscal Year 2022 Financial Results - Yahoo FinanceFebruary 3, 2022 | streetinsider.comPrestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results - StreetInsider.comFebruary 3, 2022 | finance.yahoo.comPrestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results - Yahoo FinanceJanuary 28, 2022 | businesswire.comThéa to Acquire Branded Ophthalmic Products from Akorn, Expanding Théa's Presence into the U.S. Eye Care Industry - Business WireJanuary 28, 2022 | prnewswire.comAkorn Announces Agreement to Sell its Branded Ophthalmic Products to Théa - PRNewswireJanuary 10, 2022 | streetinsider.comWhole Earth Brands (FREE) Appoints Duane Portwood as New CFO - StreetInsider.comDecember 24, 2021 | finance.yahoo.comIndia Active Pharmaceutical Ingredients Market to surpass US$ 34,968.7 Million by 2028, Says Coherent Market Insights (CMI) - Yahoo FinanceDecember 16, 2021 | uk.finance.yahoo.comInsights on the Pharma Ophthalmic Global Market to 2026 - Featuring Roche, Santen and Senju Among Others - Yahoo Finance UK Get Akorn News Delivered to You Automatically Sign up to receive the latest news and ratings for AKRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Kamala’s Secret 3-Word Plan to Destroy America… Are You Prepared? (Ad)America’s Slow Decline into Hell As Kamala Harris rises to power, her 3-word agenda threatens every American’s freedom and financial security. Get the inside scoop and learn how to protect your savings. AKRX Media Mentions By Week AKRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKRX News Sentiment▼0.000.46▲Average Medical News Sentiment AKRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKRX Articles This Week▼00▲AKRX Articles Average Week Get Akorn News Delivered to You Automatically Sign up to receive the latest news and ratings for AKRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eli Lilly and Company News Today Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Bristol-Myers Squibb News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKRX) was last updated on 9/10/2024 by MarketBeat.com Staff From Our PartnersYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredKamala’s Secret 3-Word Plan to Destroy America… Are You Prepared?America’s Slow Decline into Hell As Kamala Harris rises to power, her 3-word agenda threatens every America...Banyan Hill Publishing | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredMike Huckabee Puts His Faith in This to Protect His RetirementMike Huckabee's Urgent Warning: Safeguard Your Financial Future NowAmerican Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akorn, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akorn With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKRX Stock Alerts